In this clip from Breast Cancer Breakthroughs, Komen Scholar Dr. Sara Tolaney discusses new types of drugs on the way for people with early-stage ER-positive breast cancer currently being tested in clinical trials.
Kelsey Hampton, PhD, is Senior Manager, Mission Communications at Susan G. Komen
Dr. Sara Tolaney is a medical oncologist at Dana-Farber Cancer Institute.
Sign up for reminders about future episodes of Breast Cancer Breakthroughs here: [ Ссылка ]
Link to Survey: [ Ссылка ]
Clinical Trial Finder: [ Ссылка ]
Videos:
Breast Cancer Breakthroughs Episode 8: Navigating Breast Cancer Recurrence: [ Ссылка ]
Breast Cancer Breakthroughs Episode 7: Brining Treatments to Life: [ Ссылка ]
Resources:
Breast Cancer Recurrence: [ Ссылка ]
Emerging Areas in Drug Therapies for Early Breast Cancer: [ Ссылка ]
Hormone Therapies: [ Ссылка ]
CDK4/6 Inhibitors: [ Ссылка ]
Immunotherapy: [ Ссылка ]
Oncotype DX test: [ Ссылка ]
monarchE trial (Active, not recruiting): [ Ссылка ]
NATALEE trial (Active, not recruiting): [ Ссылка ]
